Yoshihiro Takegawa
Overview
Explore the profile of Yoshihiro Takegawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ikushima H, Iwamoto S, Osaki K, Furutani S, Yamashita K, Kawanaka T, et al.
Radiat Med
. 2008 Aug;
26(3):156-63.
PMID: 18683571
Purpose: The aim of this study was to evaluate retrospectively the toxicity and response, bladder preservation, and survival of patients with muscle-invasive bladder cancer treated with multimodality therapy consisting of...
2.
Takegawa Y, Ikushima H, Ozaki K, Furutani S, Kawanaka T, Kudoh T, et al.
J Med Invest
. 2008 Mar;
55(1-2):99-105.
PMID: 18319551
Our policy regarding the performance of radiotherapy to squamous cell carcinoma of the uterine cervix has not changed since 1969. We have already reported the treatment results which were as...
3.
Kawanaka T, Kubo A, Ikushima H, Sano T, Takegawa Y, Nishitani H
J Med Invest
. 2008 Mar;
55(1-2):78-86.
PMID: 18319549
Hypoxia-inducible factor (HIF)-2alpha, a basic helix-loop-helix (bHLH)-PAS protein, is the principal regulator of the hypoxic transcriptional response. An immunohistochemical study reported strong HIF-2alpha expression in the cytoplasm of tumor infiltrative...
4.
Ikushima H, Takegawa Y, Osaki K, Furutani S, Yamashita K, Kawanaka T, et al.
Gynecol Oncol
. 2007 Aug;
107(2):339-43.
PMID: 17707075
Objective: To evaluate the long-term results of radical radiation therapy (RT) for cervical cancer in elderly patients. Methods: We reviewed the clinical records of 727 patients with cervical cancer who...
5.
Furutani S, Saze T, Ikushima H, Oita M, Ozaki K, Kishida Y, et al.
Int J Radiat Oncol Biol Phys
. 2006 Sep;
66(2):603-9.
PMID: 16966003
Purpose: OncoSeed is delivered in a sterile environment in the form of a cartridge, so it is impractical to resterilize and reload seeds after calibration. We investigated a new method...
6.
Noda K, Ohashi Y, Okada H, Ogita S, Ozaki M, Kikuchi Y, et al.
Jpn J Clin Oncol
. 2006 Aug;
36(9):570-7.
PMID: 16926224
Objective: To find the optimal dose of immunomodulator Z-100 in patients with stage IIIB squamous cell carcinoma of the cervix in combination with radiation therapy. Methods: The patients were randomly...
7.
Ikushima H, Osaki K, Furutani S, Yamashita K, Kawanaka T, Kishida Y, et al.
Radiat Med
. 2006 May;
24(2):115-21.
PMID: 16715672
Purpose: To retrospectively evaluate the toxicity of concurrent weekly cisplatin and radiation therapy (RT) for locally advanced cervical cancer. Materials And Methods: Between April 2001 and December 2004, 21 consecutive...
8.
Furutani S, Ikushima H, Ozaki K, Oita M, Sasaki M, Takegawa Y, et al.
Radiat Med
. 2006 Feb;
23(7):474-7.
PMID: 16485537
Purpose: We evaluated a self-color developing sheet-type film for the detection of dead seeds in I-125 permanent implant therapy for prostate cancer. Materials And Methods: As a preliminary study, we...
9.
Noda K, Ohashi Y, Sugimori H, Ozaki M, Niibe H, Ogita S, et al.
Gynecol Oncol
. 2005 Dec;
101(3):455-63.
PMID: 16360199
Background: To evaluate the efficacy of low or high-dose immunomodulator, Z-100, in combination with radiotherapy for cervical cancer. Methods: Between 1995 and 1999, 221 patients with stage IIIb squamous cell...